BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 4041182)

  • 1. Kinetic studies on the interaction of streptokinase and other plasminogen activators with plasminogen and fibrin.
    Fears R; Hibbs MJ; Smith RA
    Biochem J; 1985 Jul; 229(2):555-8. PubMed ID: 4041182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interaction of streptokinase.plasminogen activator complex, tissue-type plasminogen activator, urokinase and their acylated derivatives with fibrin and cyanogen bromide digest of fibrinogen. Relationship to fibrinolytic potency in vitro.
    Cassels R; Fears R; Smith RA
    Biochem J; 1987 Oct; 247(2):395-400. PubMed ID: 3122725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of plasminogen activator to fibrin.
    Chesterman CN; Allington MJ; Sharp AA
    Nat New Biol; 1972 Jul; 238(79):15-7. PubMed ID: 18663837
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of the esterase and human plasminogen activator activities of various activated forms of human plasminogen and their equimolar streptokinase complexes.
    Wohl RC; Arzadon L; Summaria L; Robbins KC
    J Biol Chem; 1977 Feb; 252(4):1141-7. PubMed ID: 851483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue plasminogen activator and urokinase mediate the binding of Glu-plasminogen to plasma fibrin I. Evidence for new binding sites in plasmin-degraded fibrin I.
    Harpel PC; Chang TS; Verderber E
    J Biol Chem; 1985 Apr; 260(7):4432-40. PubMed ID: 3156857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequence of formation of molecular forms of plasminogen and plasmin-inhibitor complexes in plasma activated by urokinase or tissue-type plasminogen activator.
    Thorsen S; Müllertz S; Suenson E; Kok P
    Biochem J; 1984 Oct; 223(1):179-87. PubMed ID: 6208894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mechanisms of the activation of plasminogen by streptokinase and urokinase.
    Takada Y; Takada A
    Adv Exp Med Biol; 1990; 281():223-34. PubMed ID: 2102613
    [No Abstract]   [Full Text] [Related]  

  • 8. The rapid fibrin plate - a method for plasminogen activator assay.
    Marsh NA; Gaffney PJ
    Thromb Haemost; 1977 Aug; 38(2):545-51. PubMed ID: 579495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of plasminogen by pro-urokinase. I. Mechanism.
    Lijnen HR; Zamarron C; Blaber M; Winkler ME; Collen D
    J Biol Chem; 1986 Jan; 261(3):1253-8. PubMed ID: 2935528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical pharmacological evaluation of anisoylated plasminogen streptokinase activator complex.
    Ferres H
    Drugs; 1987; 33 Suppl 3():33-50. PubMed ID: 3315613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. H-D-val-leu-lys-aminoisophthalic acid, dimethyl ester, is sensitive to streptokinase-activator not to plasmin.
    Ts'ao C; Galluzzo TS
    Am J Clin Pathol; 1981 Mar; 75(3):372-7. PubMed ID: 6452054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of human neo-plasminogen-Val442 by urokinase and streptokinase and a kinetic characterization of neoplasmin-Val442.
    Powell JR; Castellino FJ
    J Biol Chem; 1980 Jun; 255(11):5329-35. PubMed ID: 6445361
    [No Abstract]   [Full Text] [Related]  

  • 13. Initial plasmin-degradation of fibrin as the basis of a positive feed-back mechanism in fibrinolysis.
    Suenson E; Lützen O; Thorsen S
    Eur J Biochem; 1984 May; 140(3):513-22. PubMed ID: 6233145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of nonproteolytic active site formation in plasminogen.
    Gladysheva IP; Sazonova IY; Houng A; Hedstrom L; Reed GL
    Biochemistry; 2007 Jul; 46(30):8879-87. PubMed ID: 17616171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of heparin with plasminogen activators and plasminogen: effects on the activation of plasminogen.
    Andrade-Gordon P; Strickland S
    Biochemistry; 1986 Jul; 25(14):4033-40. PubMed ID: 2943315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acoustic determination of performance and equivalence of plasminogen activators.
    Ghazali M; Hayward GL
    Anal Bioanal Chem; 2008 Nov; 392(5):897-902. PubMed ID: 18759103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic analyses of potentiation of plasminogen activation by streptokinase in the presence of fibrin or its degradation products.
    Takada Y; Takada A
    Haemostasis; 1987; 17(1-2):1-7. PubMed ID: 3596355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic studies on novel plasminogen activators. Demonstration of fibrin enhancement for hybrid enzymes comprising the A-chain of plasmin (Lys-78) and B-chain of tissue-type plasminogen activator (Ile-276) or urokinase (Ile-159).
    Fears R; Dodd I; Ferres H; Robinson JH
    Biochem J; 1990 Mar; 266(3):693-6. PubMed ID: 2139324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of Val442-plasminogen (mini-plasminogen) by urokinase, streptokinase and tissue plasminogen activator.
    Takada A; Takada Y; Sugawara Y
    Thromb Res; 1988 Jan; 49(2):253-63. PubMed ID: 3129817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A transitional state of pro-urokinase that has a higher catalytic efficiency against glu-plasminogen than urokinase.
    Liu JN; Pannell R; Gurewich V
    J Biol Chem; 1992 Aug; 267(22):15289-92. PubMed ID: 1639775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.